274 Participants Needed

NuestraSaludSegura Program for COVID-19 Testing and Vaccination

LL
SD
Overseen ByScott D Rhodes, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Wake Forest University Health Sciences
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Latinx communities are disproportionately affected by the COVID-19 pandemic, with Spanish-speaking Latinx communities carrying even heavier burdens of infection, hospitalization, and mortality. Major barriers to COVID-19 testing and vaccination exist, and a profound need remains to understand and address the social, ethical, and behavioral implications (SEBI) of COVID-19 testing and vaccination within Latinx communities. Our community-academic partnership proposes a rigorous mixed-methods, community-based participatory research study to better understand the SEBI of COVID-19 testing and vaccination and to refine and test a novel and culturally congruent intervention that integrates two evidenced-based strategies - peer navigation and mHealth - to increase COVID-19 testing and vaccination within Spanish-speaking Latinx communities.

Who Is on the Research Team?

SD

Scott D Rhodes, PhD

Principal Investigator

Wake Forest University Health Sciences

Are You a Good Fit for This Trial?

This trial is for Spanish-speaking individuals who are at least 18 years old and self-identify as Hispanic/Latinx. They must provide informed consent to participate. For certain parts of the study, participants also need to have received a COVID-19 vaccination.

Inclusion Criteria

To join the NuestraSaludSegura intervention as a Navegante, you must identify yourself as Hispanic/Latinx.
You have received the COVID-19 vaccine.
participant must provide informed consent
See 2 more

Exclusion Criteria

I am under 18 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention Implementation

Implementation of a culturally congruent intervention using peer navigation and mHealth to increase COVID-19 testing and vaccination

12 weeks

Evaluation

Evaluation of the intervention using a longitudinal group-randomized trial design

8 weeks

Follow-up

Participants are monitored for the effectiveness of the intervention in increasing COVID-19 testing and vaccination

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • NuestraSaludSegura
Trial Overview The study aims to understand barriers faced by Latinx communities in accessing COVID-19 testing and vaccinations. It will test 'NuestraSaludSegura', which combines peer navigation with mobile health (mHealth) strategies, designed specifically for Spanish speakers.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Spanish-speaking Latinx communitiesExperimental Treatment1 Intervention
Individual in-depth interviews with Spanish-speaking Latinx participants

Find a Clinic Near You

Who Is Running the Clinical Trial?

Wake Forest University Health Sciences

Lead Sponsor

Trials
1,432
Recruited
2,506,000+

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Trials
473
Recruited
1,374,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security